Congressman James Greenwood Was Right on Prescription Drug Importation
In 2001, in a Wall Street Journal article called “Survey Shows U.S. Customs Allows Illegal Foreign Medication,” then Congressman James Greenwood (R-PA) expressed his belief that Americans who import medications, even illegally, for their own use, should be able to. As president and chief executive of the Biotechnology Innovation Organization (BIO), which represents leading biopharmaceutical companies (such as Abbvie, Amgen, Celgene, and Gilead), he has changed his tune.
Flashback to 2001…
Congressman Greenwood, who chaired the House Commerce oversight committee, stuck up for cash strapped older Americans. Congressman Greenwood said:
“While we would like to stop dangerous drugs from being brought in for abuse and stop people from getting drugs that are counterfeit or bogus, we don’t want to interfere … with an older person getting a better buy.”
He was referring to Americans importing small quantities of non-controlled, prescription drugs for their own use because they cost a lot less money than at U.S. pharmacies.
Fast forward to 2017… (more…)
Tagged with: bio, biotechnology innovation organization, james greenwood